Ontario collaboration aims to predict and prevent cancer recurrence before it happens - Ontario Institute for Cancer Research OICR is leading a province-wide initiative to advance molecular residual disease (MRD) research and bring tests to patients. “Did you get it all?” It's often the first question a patient asks after cancer treatment, and one of the toughest questions for...

OICR is leading a new Ontario‑wide collaboration focused on advancing molecular residual disease research, using cutting‑edge blood tests to detect tiny traces of cancer that can remain after treatment and lead to recurrence.

Read more 👉 https://bit.ly/4enOj2P

#OICR #cancerresearch

PIR “Fai da te”: approccio look through PIR “Fai da te”: approccio look through anche con OICR non compliant per i veicoli di investimento collettivo per analizzarne la composizione effettiva.

#PIR “Fai da te”: approccio look through anche con #OICR non compliant - #Misterfisco